Status:
COMPLETED
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
Lead Sponsor:
Ipsen
Conditions:
Growth Hormone Disorders
Eligibility:
All Genders
Brief Summary
This study is a multicenter, open-label, observational, post marketing surveillance program to collect information on the use of NutropinAq® in adults suffering from Growth Hormone Deficiency in Germa...
Eligibility Criteria
Inclusion
- Patients with Growth Hormone Deficiency
- Patients treated with NutropinAq®
- Patients having completed growth (fused epiphyses)
Exclusion
- Active neoplasia
- Pregnancy
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
546 Patients enrolled
Trial Details
Trial ID
NCT00455884
Start Date
June 1 2006
End Date
December 1 2011
Last Update
January 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ipsen Central Contact
Slough, Berkshire, United Kingdom, SL1 3XE